Heart & Vascular Health
Cardiovascular risk and prevention
Cardiovascular Disease Risk
An integrated estimate from your risk factors
Relative Cardiovascular Risk (SCORE2, under 40)
For adults under 40: SCORE2, ASCVD, and PROCAM
Absolute Cardiovascular Risk (SCORE2, 40–65)
10-year risk for ages 40–65: SCORE2, ASCVD, and PROCAM
PREVENT (Cardiovascular Risk)
10- and 30-year cardiovascular risk from the AHA PREVENT model (2023)
Dyslipidemias
Lipid disorders: cholesterol, triglycerides, LDL/HDL
Dyslipidemia Prediction
The likelihood of a lipid disorder from your risk factors
Lipid Management
Your LDL targets and treatment approach by cardiovascular risk
Lipid Risk Factors
Atherogenic fractions and lipid-profile indices
Lp(a) Risk
Lipoprotein(a) as an independent cardiovascular risk factor
Liver Health
Indices and scores for liver fibrosis, steatosis, and function
R-Factor
Shows what's driving the injury — cholestasis or liver-cell death
Fatty Liver Index (FLI)
Estimates the likelihood of fatty liver without imaging
Hepatic Steatosis Index (HSI)
The same steatosis screening, using a different set of labs
Lipid Accumulation Product (LAP)
Detects hidden visceral fat — the backdrop for liver disease
ANI (Alcoholic Liver Index)
Distinguishes the cause of injury: alcoholic or metabolic
NAFLD Liver Fat Score
Predicts fatty liver disease with a focus on insulin and metabolism
FIB-4 (Liver Fibrosis)
A first-line check for liver scarring, adjusted for age
Liver Steatosis Score (LSS)
A calculated alternative to elastography: fibrosis likelihood from blood tests
NAFLD Fibrosis Score (NFS)
Assesses advanced fibrosis in NAFLD from simple labs and BMI
Fibrosis-NAFLD Index (FNI)
Screens for fibrotic NASH from three labs in metabolically at-risk patients
FibroTest
A non-invasive estimate of fibrosis stage — an alternative to biopsy
SAFE Score
Assesses the risk of significant fibrosis (F2+) in NAFLD from labs and BMI
Metabolic Health
Body composition, visceral fat, and metabolic risk
Body Fat
Your body fat percentage and the norms for your sex and age
Body Mass Index (BMI)
BMI and BMI Prime, WHO norms, waist-based risk, and the link to biological age
Waist-Hip Ratio (WHR)
Your fat distribution, body shape, and cardiometabolic risk
Waist-to-Height Ratio (WtHR)
Abdominal fat and cardiometabolic risk from your waist-to-height ratio
Body Composition
Body fat, muscle mass (FFMI, SMM, SMI), body shape, and ABSI — all in one
Metabolic Index
An integrated assessment of your metabolic status
Cardiometabolic Index (CMI)
TG/HDL × waist-to-height ratio — visceral and lipid risk
Insulin Resistance
HOMA-IR and markers of insulin sensitivity
Insulin Resistance Risk
Risk screening from your factors and baseline measures
Insulin Resistance Indices (Non-Insulin)
TyG, TG/HDL, and more — no insulin measurement required
HOMA2 (Insulin Resistance)
The HOMA2 model: beta-cell function, sensitivity, and IR
Insulin Resistance Indices (Insulin-Based)
HOMA-IR, QUICKI, Matsuda, and more — from measured insulin
Diabetes
Type 2 diabetes risk and glycemic control
Kidney Health
Glomerular filtration rate and nitrogen metabolism
Kidney Health
An integrated assessment of your kidney function
eGFR (Kidney Function)
CKD-EPI 2021 (creatinine), CKD-EPI 2021 (creatinine–cystatin C), and CKD-EPI 2012 (cystatin C)
BUN / Creatinine
Distinguishes prerenal, renal, and postrenal causes from urea and creatinine
Chronic Kidney Disease Risk
Predicted CKD risk from your factors and biomarkers
Hypertension
Risk and stages of elevated blood pressure
Thyroid Health
Thyroid function and thyroid-related risk
Brain Health
Cognitive risk and neurodegeneration
Gut Health
The microbiome and digestive function
Immunity
Assessing immune status and resistance
Oxidative Stress
The balance of free radicals and antioxidant defense